Who invested in Thor Therapeutics?
Thor Therapeutics's investors include Alteogen, BioHealthcare Association (BHA) related investment fund and The Eroun Partners.
South Korea · Series A startup
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised this month
Follow Thor Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
Undisclosedraised across 1 round since 2026, from 1 source
Reported by Google News search
Thor Therapeutics's investors include Alteogen, BioHealthcare Association (BHA) related investment fund and The Eroun Partners.
Thor Therapeutics has raised 1 round since 2026, none with a disclosed amount.
Thor Therapeutics's most recent round was a Series A in Nov 2026.
Thor Therapeutics's first round on record, in Nov 2026, was backed by Alteogen, BioHealthcare Association (BHA) related investment fund and The Eroun Partners.
Thor Therapeutics's latest named round is a Series A, in Nov 2026.
Thor Therapeutics is based in South Korea.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.